ENTA Competitors & Alternatives

Compare Enanta Pharmaceuticals Inc with similar stocks in the same industry

Biotechnology

ENTA

Main Stock
$11.58
Tradestie Score
53
Market Cap
$226.82M
Revenue Growth
0.2%
Analyst Upside
+73.9%

Top Competitors

221 stocks in Biotechnology
Company Price Market Cap P/E Score Action
DRTS Alpha Tau Medical Ltd. Ordinary Shares
$9.54
$371.64M - 53 Compare
CAPR Capricor Therapeutics Inc
$26.61
$357.51M - 56 Compare
CGEM Cullinan Therapeutics, Inc. Common Stock
$13.77
$354.45M - 50 Compare
LBRX LB Pharmaceuticals Inc Common Stock
$28.32
$353.70M - 56 Compare
PROK ProKidney Corp. Class A Ordinary Shares
$1.65
$350.98M - 53 Compare
ALT Altimmune, Inc. Common Stock
$2.60
$341.56M - 55 Compare
ANNX Annexon, Inc. Common Stock
$4.53
$332.96M - 47 Compare
REPL Replimune Group, Inc.
$8.89
$328.62M - 61 Compare
CADL Candel Therapeutics, Inc. Common Stock
$8.52
$304.12M - 58 Compare
JBIO Jade Biosciences, Inc. Common Stock
$15.87
$297.23M - 49 Compare

Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)

221 stocks in this industry